Skip Navigation   My NYSBA | | Join | Renew | Web Survey | FAQ | Online Store | About NYSBA | Contact | Site Map
New York State Bar Association
Food, Drug and Cosmetic Law
Join This Section/Section Brochure
Executive Committee and Past Chairs
Committee Rosters
Upcoming Events
Annual Meeting 2012
Annual Meeting Programs 2000-2012
Coffee, Croissants and Bagels CLE Series
May 8, 2012 Program
Food, Drug, Cosmetic and Medical Device Law Digest
Past Special Programs
Site Map
For the Media
Government Relations
Law, Youth & Citizenship
Lawyer Assistance Program
Lawyer Referral Service
Pro Bono Affairs
Conference of Bar Leaders
THE NEW YORK
BAR FOUNDATION
Connect with NYSBA
 
  
Advanced Search       Search Tips

THE INTERPLAY BETWEEN
THE FOOD, DRUG AND COSMETIC ACT
AND
FALSE ADVERTISING LAW

March 24, 2009

View the Program Flyer here.

Kramer Levin Naftalis & Frankel LLP and the National Advertising Division (NAD) of the Council of Better Business Bureaus hosted, at the firm’s law offices in New York City, the first Coffee, Croissants and CLE Program Kramer Levin litigation partners Harold P. Weinberger and Norman C. Simon, and NAD Staff Attorney Kathleen Dunnigan led the program. 

The presentation, entitled The Interplay between the Food, Drug & Cosmetic Act and False Advertising Law, examined the relationship between the Food Drug and Cosmetic Act and the Lanham Act, the federal law under which false advertising claims are brought.  The presentation examined how and when statements about Food and Drug Administration approval of a drug, or claims related to a drug’s bioequivalence or superiority to a generic version, may be challenged under the Lanham Act or through a proceeding brought at NAD. 

To provide background for this discussion, Messrs. Weinberger and Simon provided a broad overview of the types of actionable claims that may be brought under the Lanham Act, the types of proof required to support such claims and the types of damages available to successful plaintiffs.  As a counterpoint to this discussion, Ms. Dunnigan highlighted the differences between Lanham Act and NAD challenges, such as differing burdens of proof and remedies, as well as a program of voluntary compliance with NAD decisions.

ImageImage
ImageImage